RO8191
RO8191 (CDM-3008), an imidazonaphthyridine compound, is an orally active and potent interferon (IFN) receptor agonist. RO8191 directly binds to IFNα/β receptor 2 (IFNAR2) and activates IFN-stimulated genes (ISGs) expression and JAK/STAT phosphorylation. RO8191 shows antiviral activity against both HCV and EMCV with an IC50 of 200 nM for HCV replicon[1]. RO8191 is a cccDNA modulator (CDM) through interferon-like activity and has anti-HBV activity[2].
Product Specifications
CAS Number
691868-88-9
Product Name Alternative
CDM-3008; RO4948191
UNSPSC
12352005
Hazard Statement
H315, H319
Target
HBV; HCV; IFNAR; JAK; STAT
Type
Reference compound
Related Pathways
Anti-infection; Epigenetics; Immunology/Inflammation; JAK/STAT Signaling; Protein Tyrosine Kinase/RTK; Stem Cell/Wnt
Applications
COVID-19-anti-virus
Field of Research
Infection
Assay Protocol
https://www.medchemexpress.com/ro8191.html
Purity
99.0
Solubility
DMSO : 5 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
FC(C1=C2C=CC3=NC(C4=NN=CO4)=CN3C2=NC(C(F)(F)F)=C1)(F)F
Molecular Formula
C14H5F6N5O
Molecular Weight
373.21
Precautions
H315, H319
References & Citations
Shipping Conditions
Blue Ice
Storage Conditions
-20°C (Powder, stored under nitrogen)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
JAK1
Available Sizes
Frequently Asked Questions
Explore Other Products
Browse additional items from our catalog
Guinea Pig Olfactory receptor 10K2 (OR10K2) ELISA kit
Rabbit anti-Oryza sativa subsp. japonica (Rice) PRXIIC Polyclonal Antibody
